Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70

Hematologic malignancies in older people are unlikely to be cured with chemotherapy alone. Advances in allogeneic blood or marrow transplantation (alloBMT), especially nonmyeloablative (NMA) conditioning and the use of haploidentical donors, now make this therapy available to older people; however,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Blood Adv
Auteurs principaux: Imus, Philip H., Tsai, Hua-Ling, Luznik, Leo, Fuchs, Ephraim J., Huff, Carol Ann, Gladstone, Douglas E., Lowery, Patrick, Ambinder, Richard F., Borrello, Ivan M., Swinnen, Lode J., Wagner-Johnston, Nina, Gocke, Christian B., Ali, Syed Abbas, Bolaños-Meade, F. Javier, Varadhan, Ravi, Jones, Richard J.
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2019
Sujets:
Transplantation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6737415/
https://ncbi.nlm.nih.gov/pubmed/31492679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000155
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires